EP0742830 - FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.05.2002 Database last updated on 31.08.2024 | Most recent event Tooltip | 04.01.2008 | Lapse of the patent in a contracting state New state(s): CH, IT, LI | published on 06.02.2008 [2008/06] | Applicant(s) | For all designated states THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Office of Technology Transfer, 6011 Executive Blvd., Suite 325 Rockville Maryland 20852 / US | [N/P] |
Former [1996/51] | For all designated states THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Office of Technology Transfert, 6011 Executive Blvd., Suite 325 Rockville, Maryland 20852 / US | ||
Former [1996/47] | For all designated states THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Health, Office of Technology Transfer, Westwood Building, Box OTT Bethesda, MD 20892-9902 / US | Inventor(s) | 01 /
LAROCHELLE, William, J. 18812 Purple Martin Lane Gaithersburg, MD 20879 / US | 02 /
AARONSON, Stuart, A. 1006 Harriman Street Great Falls, VA 22066 / US | 03 /
DIRSCH, Olaf 5327 McKinley Street Bethesda, MD 20814 / US | [1996/47] | Representative(s) | Warcoin, Jacques, et al Cabinet Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | [N/P] |
Former [1996/47] | Warcoin, Jacques, et al Cabinet Régimbeau, 26, avenue Kléber 75116 Paris / FR | Application number, filing date | 95908666.1 | 01.02.1995 | [1996/47] | WO1995US00974 | Priority number, date | US19940189552 | 01.02.1994 Original published format: US 189552 | [1996/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9521258 | Date: | 10.08.1995 | Language: | EN | [1995/34] | Type: | A1 Application with search report | No.: | EP0742830 | Date: | 20.11.1996 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.08.1995 takes the place of the publication of the European patent application. | [1996/47] | Type: | B1 Patent specification | No.: | EP0742830 | Date: | 18.07.2001 | Language: | EN | [2001/29] | Search report(s) | International search report - published on: | EP | 10.08.1995 | Classification | IPC: | C12N15/62, C07K19/00, C07K16/00, C07K14/71, G01N33/566 | [1996/47] | CPC: |
C07K14/71 (EP,US);
C07K16/00 (EP,US);
A61K38/00 (EP,US);
C07K2319/02 (EP,US)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/47] | Title | German: | FUSIONIERTE PROTEINE DIE ANTIKÖRPER-TEILE UND NICHT-ANTIKÖRPER-TEILE ENTHALTEN | [1996/47] | English: | FUSION PROTEINS THAT INCLUDE ANTIBODY AND NONANTIBODY PORTIONS | [1996/47] | French: | PROTEINES DE FUSION COMPRENANT DES PARTIES ANTICORPS ET NON ANTICORPS | [2001/09] |
Former [1996/47] | PROTEINES DE FUSION COMPRENANT DES PARTIES ANTICORPALES ET NON ANTICORPALES | Entry into regional phase | 26.08.1996 | National basic fee paid | 26.08.1996 | Designation fee(s) paid | 14.10.1996 | Examination fee paid | Examination procedure | 30.08.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 14.10.1996 | Examination requested [1996/50] | 09.11.1998 | Despatch of a communication from the examining division (Time limit: M04) | 15.03.1999 | Reply to a communication from the examining division | 08.09.1999 | Despatch of a communication from the examining division (Time limit: M06) | 21.02.2000 | Reply to a communication from the examining division | 29.08.2000 | Despatch of communication of intention to grant (Approval: No) | 29.12.2000 | Despatch of communication of intention to grant (Approval: later approval) | 15.01.2001 | Communication of intention to grant the patent | 26.03.2001 | Fee for grant paid | 26.03.2001 | Fee for publishing/printing paid | Opposition(s) | 19.04.2002 | No opposition filed within time limit [2002/28] | Fees paid | Renewal fee | 26.02.1997 | Renewal fee patent year 03 | 26.01.1998 | Renewal fee patent year 04 | 25.01.1999 | Renewal fee patent year 05 | 21.01.2000 | Renewal fee patent year 06 | 22.01.2001 | Renewal fee patent year 07 | Penalty fee | Penalty fee Rule 85b EPC 1973 | 09.10.1996 | M01   Fee paid on   14.10.1996 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 18.07.2001 | BE | 18.07.2001 | CH | 18.07.2001 | IT | 18.07.2001 | LI | 18.07.2001 | NL | 18.07.2001 | DK | 18.10.2001 | PT | 18.10.2001 | SE | 18.10.2001 | GR | 19.10.2001 | ES | 31.01.2002 | IE | 01.02.2002 | LU | 01.02.2002 | [2008/06] |
Former [2004/51] | AT | 18.07.2001 | |
BE | 18.07.2001 | ||
NL | 18.07.2001 | ||
DK | 18.10.2001 | ||
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
GR | 19.10.2001 | ||
ES | 31.01.2002 | ||
IE | 01.02.2002 | ||
LU | 01.02.2002 | ||
Former [2004/39] | AT | 18.07.2001 | |
BE | 18.07.2001 | ||
NL | 18.07.2001 | ||
DK | 18.10.2001 | ||
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
ES | 31.01.2002 | ||
IE | 01.02.2002 | ||
LU | 01.02.2002 | ||
Former [2004/04] | AT | 18.07.2001 | |
BE | 18.07.2001 | ||
NL | 18.07.2001 | ||
DK | 18.10.2001 | ||
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
ES | 31.01.2002 | ||
IE | 01.02.2002 | ||
Former [2003/45] | AT | 18.07.2001 | |
BE | 18.07.2001 | ||
NL | 18.07.2001 | ||
DK | 18.10.2001 | ||
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
IE | 01.02.2002 | ||
Former [2003/17] | AT | 18.07.2001 | |
BE | 18.07.2001 | ||
NL | 18.07.2001 | ||
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
IE | 01.02.2002 | ||
Former [2003/08] | AT | 18.07.2001 | |
BE | 18.07.2001 | ||
NL | 18.07.2001 | ||
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
Former [2002/29] | AT | 18.07.2001 | |
BE | 18.07.2001 | ||
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
Former [2002/26] | AT | 18.07.2001 | |
PT | 18.10.2001 | ||
SE | 18.10.2001 | ||
Former [2002/15] | AT | 18.07.2001 | |
SE | 18.10.2001 | ||
Former [2002/05] | SE | 18.10.2001 | Cited in | International search | [Y]EP0325224 (ZYMOGENETICS INC [US]) [Y] 1-26* example 12D * | [Y] - MARK ET AL., "Expression and characterization of Hepatocyte Growth Factor Receptor-IgG fusion proteins", JOURNAL OF BIOLOGICAL CHEMISTRY (MICROFILMS), MD US, (19921225), vol. 267, no. 36, pages 26166 - 26171 [Y] 1-26 * figure 1 * | [Y] - LYMAN ET AL., "Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferaive factor for primitive hematopoietic cells", CELL, NA US, (19931217), vol. 75, no. 6, pages 1157 - 1167 [Y] 1-26 * page 1164, column L, paragraph 2 * | [PX] - CHEON ET AL., "High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, WASHINGTON US, (19940201), vol. 91, no. 3, pages 989 - 993 [PX] 1-26 * the whole document * | [PX] - HEIDARAN ET AL., "betaPDGFR-IgG chimera demonstrates that human betaPDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding", FASEB JOURNAL FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD US, vol. 9, no. 1, pages 140 - 145 [PX] 1-26 * the whole document * |